PubMed Health⌕ Search

Biomedical subjects

H van Maanen

Publications and source records attributed to H van Maanen.

8 recordsLinked to original sources

[Premature and over-simplified publication of mortality differences between hospitals in the media].

Prismant, the major institute for health-care research in the Netherlands, presented differences in mortality data from hospitals in the Netherlands. The data from the Prismant study were front-page news. However, the Prismant study was only published on their own website, and contained only raw data. The author did not consider relevant issues, e.g., the differences in case mix in the various hospitals and demographic factors. The public debate on quality of health care would benefit greatly if research institutes published only data that were peer reviewed and if journalists checked with experts before they published an article on such a specialist medical issue.

Hospital Mortality↗

[The biased information given to women about population screening for breast cancer makes a well considered informed choice to participate unlikely].

The 'Wet op de Geneeskundige Behandelingsovereenkomst' (Act on Agreement Concerning Medical Treatment) requires that patients are clearly informed about 'the risks and consequences that can be expected from an intended treatment or investigation'. The information received by women aged 50-74 years when invited for a biannual investigation for breast cancer does not satisfy the requirements: the available knowledge is presented too favourably and it is therefore not possible to make a well-considered informed choice to participate. For example, in the group to be screened, 4000 cases of breast cancer are diagnosed each year, yet in the information leaflet a figure of 9000 is stated, the number for all age categories. Furthermore, these 9000 cases include 1500 cases detected only as a result of screening. In the information leaflet no mention is made of the fact that 1 in 5 women will die despite screening and the risk of interval carcinomas is not examined; 40% of malignant mammary tumours are still found outside of the screening programme.

Aged↗

[Nursing science in oncologic nursing].

The nursing care of cancer patients has increased in complexity over the past 20 years. Cancer nurses are offering highly specialized care that is frequently delivered in teamwork in hospitals as well as in the community. Cancer nursing uses the development of nursing science and research. Nurses could not be accountable for their practice if this expert knowledge was not made accessible to them. This article focuses on nursing science as a new development in clinical nursing practice in Germany, it identifies why cancer nursing is so demanding on part of the patients, their families (significant others) and professional nurses. Research studies are discussed to demonstrate how scientific knowledge can support the nursing expert in the development of cancer nursing care, a well developed domain of nursing science.

Germany↗